Cargando…

The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro

The human immunodeficiency virus type 1 (HIV-1) is a primate lentivirus that causes the acquired immunodeficiency syndrome (AIDS). In addition to the virion structural proteins and enzyme precursors, that are Gag, Env and Pol, HIV-1 encodes several regulatory proteins, notably a small nuclear transc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuciak, Monika, Gabus, Caroline, Ivanyi-Nagy, Roland, Semrad, Katharina, Storchak, Roman, Chaloin, Olivier, Muller, Sylviane, Mély, Yves, Darlix, Jean-Luc
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
RNA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2425468/
https://www.ncbi.nlm.nih.gov/pubmed/18442994
http://dx.doi.org/10.1093/nar/gkn177
_version_ 1782156261642469376
author Kuciak, Monika
Gabus, Caroline
Ivanyi-Nagy, Roland
Semrad, Katharina
Storchak, Roman
Chaloin, Olivier
Muller, Sylviane
Mély, Yves
Darlix, Jean-Luc
author_facet Kuciak, Monika
Gabus, Caroline
Ivanyi-Nagy, Roland
Semrad, Katharina
Storchak, Roman
Chaloin, Olivier
Muller, Sylviane
Mély, Yves
Darlix, Jean-Luc
author_sort Kuciak, Monika
collection PubMed
description The human immunodeficiency virus type 1 (HIV-1) is a primate lentivirus that causes the acquired immunodeficiency syndrome (AIDS). In addition to the virion structural proteins and enzyme precursors, that are Gag, Env and Pol, HIV-1 encodes several regulatory proteins, notably a small nuclear transcriptional activator named Tat. The Tat protein is absolutely required for virus replication since it controls proviral DNA transcription to generate the full-length viral mRNA. Tat can also regulate mRNA capping and splicing and was recently found to interfere with the cellular mi- and siRNA machinery. Because of its extensive interplay with nucleic acids, and its basic and disordered nature we speculated that Tat had nucleic acid-chaperoning properties. This prompted us to examine in vitro the nucleic acid-chaperoning activities of Tat and Tat peptides made by chemical synthesis. Here we report that Tat has potent nucleic acid-chaperoning activities according to the standard DNA annealing, DNA and RNA strand exchange, RNA ribozyme cleavage and trans-splicing assays. The active Tat(44–61) peptide identified here corresponds to the smallest known sequence with DNA/RNA chaperoning properties.
format Text
id pubmed-2425468
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-24254682008-06-12 The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro Kuciak, Monika Gabus, Caroline Ivanyi-Nagy, Roland Semrad, Katharina Storchak, Roman Chaloin, Olivier Muller, Sylviane Mély, Yves Darlix, Jean-Luc Nucleic Acids Res RNA The human immunodeficiency virus type 1 (HIV-1) is a primate lentivirus that causes the acquired immunodeficiency syndrome (AIDS). In addition to the virion structural proteins and enzyme precursors, that are Gag, Env and Pol, HIV-1 encodes several regulatory proteins, notably a small nuclear transcriptional activator named Tat. The Tat protein is absolutely required for virus replication since it controls proviral DNA transcription to generate the full-length viral mRNA. Tat can also regulate mRNA capping and splicing and was recently found to interfere with the cellular mi- and siRNA machinery. Because of its extensive interplay with nucleic acids, and its basic and disordered nature we speculated that Tat had nucleic acid-chaperoning properties. This prompted us to examine in vitro the nucleic acid-chaperoning activities of Tat and Tat peptides made by chemical synthesis. Here we report that Tat has potent nucleic acid-chaperoning activities according to the standard DNA annealing, DNA and RNA strand exchange, RNA ribozyme cleavage and trans-splicing assays. The active Tat(44–61) peptide identified here corresponds to the smallest known sequence with DNA/RNA chaperoning properties. Oxford University Press 2008-06 2008-04-28 /pmc/articles/PMC2425468/ /pubmed/18442994 http://dx.doi.org/10.1093/nar/gkn177 Text en © 2008 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle RNA
Kuciak, Monika
Gabus, Caroline
Ivanyi-Nagy, Roland
Semrad, Katharina
Storchak, Roman
Chaloin, Olivier
Muller, Sylviane
Mély, Yves
Darlix, Jean-Luc
The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro
title The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro
title_full The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro
title_fullStr The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro
title_full_unstemmed The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro
title_short The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro
title_sort hiv-1 transcriptional activator tat has potent nucleic acid chaperoning activities in vitro
topic RNA
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2425468/
https://www.ncbi.nlm.nih.gov/pubmed/18442994
http://dx.doi.org/10.1093/nar/gkn177
work_keys_str_mv AT kuciakmonika thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT gabuscaroline thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT ivanyinagyroland thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT semradkatharina thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT storchakroman thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT chaloinolivier thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT mullersylviane thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT melyyves thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT darlixjeanluc thehiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT kuciakmonika hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT gabuscaroline hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT ivanyinagyroland hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT semradkatharina hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT storchakroman hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT chaloinolivier hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT mullersylviane hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT melyyves hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro
AT darlixjeanluc hiv1transcriptionalactivatortathaspotentnucleicacidchaperoningactivitiesinvitro